Trial Profile
A Comparative Study in the Clinical and Microbial Efficacy of Topical Besifloxocin Ophthalmic Suspension 0.6% With Erythromycin Ophthalmic Ointment 0.5% BID for the Management of Acute Blepharitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Besifloxacin (Primary) ; Erythromycin (Primary)
- Indications Bacterial infections; Blepharitis
- Focus Therapeutic Use
- 26 Nov 2011 New trial record